查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1466727

STD 檢測市場：按類型、按產品類型、按測試設定、按適應症、按最終用戶 - 2024-2030 年全球預測

STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Product Type (Instruments, Reagents & Kits), Test Settings, Indication, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年性病檢測市場規模為94.4億美元，預計2024年將達99.7億美元，2030年將達141.1億美元，複合年成長率為5.90%。

性行為感染傳染病（STD）檢測市場由用於識別性行為感染感染（STI）存在的各種醫學檢測組成。性病檢測對於保障個人健康、預防性病傳播、便於及時治療有重要作用。當症狀變得明顯時，就需要進行性傳染病檢測，鑑於許多性傳染病長期無症狀，因此需要將其作為預防性健康措施。檢測種類繁多，包括血液檢測、尿液檢查、拭子檢測和體格檢測，每種檢測都針對特定的感染疾病，如愛滋病毒、披衣菌感染、衣原體、淋病、梅毒和人類乳突病毒 (HPV)。影響性病檢測市場的關鍵成長要素包括公眾對性病的認知不斷提高、政府和非政府為遏制性病傳播所做的努力以及診斷技術的進步。提高準確性、提高可及性以及減少圍繞性病檢測的恥辱感正在進一步推動市場成長。此外，全球性傳染病盛行率不斷上升，需要持續需求有效且有效率的檢測解決方案。然而，市場面臨社會偏見、經濟限制、衛生基礎設施有限、意識缺乏等挑戰，尤其是保守和低度開發地區。透過數位健康平台和性病檢測服務的整合，性病檢測市場正在出現新的商機，為個人提供謹慎、便利的遠端解決方案。可以從單一樣本中檢測多種性傳染病的更全面的多重測試組合的開發和商業化帶來了巨大的成長機會。此外，擴展到性傳染病高流行的開拓地區，再加上公共衛生措施和教育宣傳活動，可以為性傳染病檢測市場開闢新的途徑。

主要市場統計
基準年[2023] 94.4億美元
預測年份 [2024] 99.7億美元
預測年份 [2030] 141.1億美元
複合年成長率（%） 5.90%

類型：STD 檢測，擴大偏好使用拭子檢測，因為它們是非侵入性的

拭子檢測對於診斷披衣菌感染、淋病、人類乳突病毒 (HPV) 和皰疹等性傳染病至關重要。這些測試是首選，因為它們是非侵入性的，並且允許直接從感染部位（例如尿道、陰道、子宮頸或喉嚨）採集樣本。血液檢測用於診斷B型肝炎和C型肝炎、梅毒、愛滋病毒和單純皰疹病毒。當懷疑性傳染病已進入血液或檢查是否有抗體或病原體本身時，就需要進行血液檢查。腰椎穿刺對於診斷梅毒和單純皰疹病毒引起的神經系統感染極為重要。收集腦脊髓液並檢測 STD 病原體的存在。由於該測試很複雜，因此需要在醫院中在經驗豐富的醫療專業人員的指導下進行。尿液檢查通常用於診斷披衣菌感染和淋病。簡單且非侵入性的檢體採集使其特別適合大規模篩檢計劃和自我管理測試。疑似性病、感染部位、病人舒適度等都會影響性病檢測方法的選擇。血液檢查和腰椎穿刺是侵入性的，但對於檢測全身感染疾病或影響神經系統的感染疾病是必要的。拭子檢測可以進行特異性部位的診斷，而尿液檢查以其簡單方便而聞名，適合篩檢包括披衣菌感染和淋病在內的感染疾病。

產品類型：大批量測試環境中對高通量設備的需求

性病檢測涉及的設備是用於檢測和分析引起性病的病原體的設備。包括PCR設備、ELISA讀數儀、質譜儀等。測試設備對於進行大規模、高精度測試的實驗室至關重要。設備是進行大量測試的大型醫療機構和實驗室的首選。儘管初始成本較高，但設備的耐用性和吞吐量能力為大規模業務提供了更高的效率和更低的長期測試成本。試劑和套件是專門用​​於 STD 檢測的化學或生物成分，可以與設備結合使用，也可以單獨使用，具體取決於檢測類型。包括測試程序所需的一切，包括拭子、化學試劑和對照樣品。試劑和套件受到各種醫療保健提供者的青睞，從大型實驗室到小型診所和家庭檢測服務。測試量彈性，不需要大量投資特定測試所需的設備。這些非常適合有針對性的測試或大型測試設備的使用受到限制的情況。

測試設定：POC測試因方便快速而廣受歡迎

性傳染病的實驗室檢測包括從個人身上採集樣本（血液、尿液、拭子）並將這些樣本送到專門的實驗室進行分析。眾所周知，這種方法非常準確，可以檢測多種性傳染病，包括愛滋病毒、梅毒、披衣菌感染和淋病。當需要進行全面檢測時，尤其是懷疑無症狀性感染者或多種性傳染病時，首選實驗室檢測。 POC 檢測呈陽性後，選擇實驗室檢測作為確認檢測。照護現場(POC) 測試在患者的辦公時間或地點進行，例如在醫生檢查室或診所，或在家中使用自我檢測檢測套組進行。這種方法可以快速提供結果，這對於立即做出治療決定至關重要。當需要快速獲得結果或難以使用測試設施時，POC 測試是合適的。 POC 檢測對於高風險族群特別有用，可以增加患者收到檢測結果並接受後續治療的可能性。

適應症：披衣菌感染發病率增加以及對先進檢測技術的需求

披衣菌感染是一種非常常見的細菌感染疾病，通常很少或沒有症狀。特別建議 25 歲以下的性活躍人士、有新伴侶的人或多位性伴侶的人進行檢測。基於實驗室的核酸增幅檢查（NAAT）是首選檢測方法。生殖器皰疹主要由 HSV-2 引起，可透過病毒培養測試、PCR 測試和血液抗體測試來診斷。 PCR 檢測直接檢測病毒，因其準確而受到青睞。由於抗生素抗藥性細菌的增加，淋病檢測極為重要。除披衣菌感染外，NAAT已成為淋病檢測的黃金標準。乙型肝炎（一種影響肝臟的病毒感染疾病）的篩檢需要透過血液檢測來檢測 HBV DNA 水平、表面抗原和抗體。 HIV 檢測對於疾病的早期發現和管理至關重要。測試範圍從快速抗體測試到抗原抗體組合測試和核酸測試（NAT）。人類乳突病毒（HPV）是最常見的性行為感染，某些菌株可導致子宮頸癌。此檢測主要針對女性，檢測高危險 HPV DNA 類型。梅毒檢測通常從非密螺旋體抗體檢測開始，然後透過密螺旋體抗體檢測進行確認。傳統的 RPR（快速血漿反應素）測試與較新的 EIA（酵素免疫分析）一起廣泛使用。

最終用戶：由於診斷中心性病檢測的使用增加，交貨時間更短

診斷中心專門從事各種健康狀況的檢測和分析，包括性行為感染傳染病（STD）。我們為需要全面體檢和需要保密的患者提供服務。該細分市場的需求是由易於訪問、快速測試時間和先進測試技術的可用性所推動的。患者更喜歡診斷中心進行常規篩檢和匿名。這些中心配備了最新的診斷工具，並有專家提供諮詢和即時分析。對於不需要住院治療的患者尤其優選。醫院和診所提供各種醫療服務，包括性病檢測。這些醫院和診所對於尋求全面醫療照護（包括性傳染病的診斷、治療和追蹤）的個人來說至關重要。該細分市場因其在醫療保健領域的重要作用而獲得了巨大的市場佔有率。有性傳染病症狀或需要結合檢查進行諮詢的患者更喜歡去醫院和診所。這些設施具有全面護理的優勢，患者可以在一個地方接受診斷和治療。這些設施對於應對需要專門諮詢的嚴重或複雜性病病例至關重要。診斷中心正在精簡，以提供及時且往往更實惠的檢測服務。診斷中心提供專門的治療，因此您可能需要在醫院獲得的全面醫療支援。雖然醫院和診所提供全面的護理，但在測試週轉時間方面可能無法與診斷中心相提並論。然而，他們在提供詳細的患者照護方面表現出色，包括專家的治療和諮詢。

區域洞察

美洲，特別是美國和加拿大，是重視創新和可近性的已開發市場。美國市場的特徵是消費者認知度高，並且有主導研發的大公司。最近的專利強調非侵入性測試方法和快速結果。加拿大市場優先考慮可及的醫療保健，透過公共衛生宣傳活動和對檢測中心的大量投資來提高性傳染病的認知和預防。南美洲的性病檢測市場仍然強勁，尤其是巴西，由於性病患病率不斷上升，政府專注於公共衛生宣傳活動和醫療設施的改善，以促進市場擴張。歐洲、中東和非洲的性病檢測市場呈現多樣化格局。由於完善的醫療保健系統和持續的研究舉措，歐盟 (EU) 國家對先進診斷測試的需求很高。該地區開發創新測試解決方案的官民合作關係正在不斷發展。相較之下，中東地區則致力於透過教育宣傳活動和基礎設施投資來提高公眾意識並消除性病檢測的文化障礙。儘管由於資源限制，非洲面臨著獨特的挑戰，但它見證了針對其需求的國際援助和創新檢測解決方案的增加，創造了一個負擔得起且易於獲得的性病檢測市場，這表明它正在擴大。在醫療基礎設施快速擴張、中階人口不斷成長以及政府加強公共衛生的推動下，亞太地區性病檢測市場正在快速開拓。中國、印度和澳洲等國家正在透過專注於宣傳宣傳活動和引進先進的診斷測試技術來促進這一成長。

FPNV定位矩陣

FPNV定位矩陣對於評估STD檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 STD 測試市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析也為此細分市場的競爭特徵提供了寶貴的見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.性病檢測市場規模及預測是多少？

2.在性病檢測市場的預測期內，有哪些產品、細分市場、應用程式和細分市場需要考慮投資？

3.性病檢測市場的技術趨勢和法規結構是什麼？

4.性病檢測市場主要廠商的市場佔有率為何？

5.進入性病檢測市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球性行為感染傳染病的發生率和盛行率不斷增加
      • 透過教育宣傳活動提高對性行為感染傳染病的認知
    • 抑制因素
      • 核准性病檢測產品的嚴格監管指南存在問題
    • 機會
      • 性行為感染診斷技術不斷進步
      • 增加全國的篩檢檢測並促進性病檢測的採用
    • 任務
      • 與看專科醫生相關的社會恥辱
  • 市場區隔分析
    • 類型：STD 檢測 拭子檢測越來越受歡迎，因為它們是非侵入性的
    • 產品類型：需要用於大容量測試環境的高通量設備
    • 測試設定：優先考慮 POC 測試，因其無與倫比的便利性和速度
    • 適應症：披衣菌感染發病率增加以及對先進檢測技術的需求
    • 最終用戶：擴大診斷中心性病檢測的使用並減少週轉時間
  • 市場趨勢分析
    • 家用性病檢測套組越來越受歡迎，各大公司在美洲都站穩了腳步。
    • 性行為感染的性行為感染力度
    • 診斷解決方案和創新產品的嚴格法規結構，以促進全部區域的性病檢測
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章性病檢測市場：依類型

  • 介紹
  • 驗血
  • 腰椎穿刺
  • 拭子測試
  • 尿液檢查

第7章性病檢測市場：依產品類型

  • 介紹
  • 裝置
  • 試劑和套件

第8章性病檢測市場：依檢測設置

  • 介紹
  • 實驗室
  • 照護現場

第9章性病檢測市場：依適應症分類

  • 介紹
  • 披衣菌感染
  • 生殖器皰疹
  • 淋病
  • B型肝炎
  • HIV愛滋病
  • 人類乳突病毒
  • 梅毒

第 10 章 STD 檢測市場：依最終用戶分類

  • 介紹
  • 診斷中心
  • 醫院/診所

第11章 南北美洲性病檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太性病檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲性病檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-69324464D0F2

[195 Pages Report] The STD Testing Market size was estimated at USD 9.44 billion in 2023 and expected to reach USD 9.97 billion in 2024, at a CAGR 5.90% to reach USD 14.11 billion by 2030.

Sexually transmitted disease (STD) testing market comprises various medical examinations used to identify the presence of sexually transmitted infections (STIs). STD testing plays a critical role in ensuring individual health, preventing the spread of STDs, and facilitating timely treatment. The need for STD testing arises when symptoms are apparent and as a preventive health measure, considering that many STDs may remain asymptomatic for prolonged periods. The types of tests conducted vary widely, encompassing blood tests, urine tests, swabs, and physical examinations, each targeting specific infections such as HIV, herpes, chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV). The significant growth factors impacting the STD testing market include increasing awareness about STDs among the general population, governmental and non-governmental efforts to combat the spread of STDs, and advancements in diagnostic technologies. Enhanced accuracy, accessibility, and the declining stigma associated with STD testing have further propelled the market's growth. Additionally, the rising incidence rates of STDs globally necessitate continuous demand for effective and efficient testing solutions. However, the market faces challenges, including social stigma, particularly in conservative and less-developed regions, financial constraints, limited healthcare infrastructure, and lack of awareness. New opportunities in the STD testing market are emerging from integrating digital health platforms with STD testing services, which offer discreet, convenient, and remote solutions for individuals. The development and commercialization of more comprehensive multiplex testing panels, capable of detecting multiple STDs from a single sample, present significant growth venues. Moreover, expanding into underserved regions with high STD prevalence, coupled with public health initiatives and education campaigns, can open new avenues for the STD testing market.

KEY MARKET STATISTICS
Base Year [2023] USD 9.44 billion
Estimated Year [2024] USD 9.97 billion
Forecast Year [2030] USD 14.11 billion
CAGR (%) 5.90%

Type: Increasing preference for swab tests for STD testing for their non-invasive nature

Swab tests are essential for diagnosing STDs such as chlamydia, gonorrhea, human papillomavirus (HPV), and herpes. These tests are preferred for their non-invasive nature and the ability to collect samples directly from the site of infection, such as the urethra, vagina, cervix, or throat. Blood tests are used to diagnose hepatitis B and C, syphilis, HIV, and herpes simplex virus. They are preferred when an STD is suspected to have entered the bloodstream or to check for the presence of antibodies or the pathogen itself. Lumbar puncture is crucial for diagnosing nervous system infections caused by syphilis or herpes simplex virus. It involves collecting cerebrospinal fluid to detect the presence of the STD pathogen. This procedure is conducted in hospital settings under the guidance of experienced medical professionals due to its complexity. Urine tests are frequently used for diagnosing chlamydia and gonorrhea. They are favored for their ease of sample collection and non-invasive nature, making them especially suitable for large-scale screening programs or self-administered testing. The suspected STD, the site of infection, and patient comfort influence the choice of STD testing method. Blood tests and lumbar punctures are more invasive but necessary for detecting systemic infections and those affecting the nervous system. Swab tests, offering site-specific diagnosis, and urine tests, known for their ease and convenience, are more suited for widespread screening of infections, including chlamydia and gonorrhea.

Product Type: Need for high-throughput instruments for high-volume testing environments

Instruments in STD testing are devices used for the detection and analysis of pathogens responsible for STDs. These include PCR machines, ELISA readers, and mass spectrometers. Instruments are integral in laboratories for conducting large-scale and highly accurate tests. Instruments are preferred by larger health facilities and laboratories that perform high volumes of tests. The upfront cost is higher, while instruments offer greater efficiency and lower long-term costs per test for large-scale operations due to their durability and throughput capabilities. Reagents and kits are chemical or biological components used explicitly for STD testing in conjunction with instruments or standalone, depending on the test type. These include everything necessary for the testing procedure, such as swabs, chemical reagents, and control samples. Reagents and kits are favored by varied healthcare providers, from large laboratories to smaller clinics and at-home testing services. They offer flexibility in testing volume, with no significant investment required in instrumentation for certain tests. These are ideal for targeted testing and situations where access to large laboratory instruments is limited.

Test Settings: Preference for POC tests for their unmatched convenience and speed

Laboratory testing for STDs involves collecting samples (blood, urine, or swabs) from individuals and sending these samples to a specialized laboratory for analysis. This method is known for its accuracy and the ability to test for several types of STDs, including HIV, syphilis, chlamydia, gonorrhea, and others. Laboratory testing is preferred when comprehensive testing is required, especially for asymptomatic infections or when multiple STDs are suspected. It is chosen for confirmatory testing following a positive POC test. Point-of-care (POC) testing is conducted at the time and place of patient care, such as in a doctor's office, a clinic, or even at home with self-testing kits. This method provides rapid results, which is crucial for immediate treatment decisions. POC testing is preferred in settings where rapid results are necessary or when access to laboratory facilities is unavailable. It is particularly useful for high-risk populations and to increase the chance of patients receiving their results and subsequent treatment.

Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies

Chlamydia is a highly common bacterial infection that often presents with few or no symptoms. Testing is particularly recommended for sexually active individuals under 25 and those with new or multiple partners. Laboratory-based nucleic acid amplification tests (NAATs) are the preferred method for detection. Genital Herpes, primarily caused by HSV-2, is diagnosed through viral culture tests, PCR tests, and blood tests for antibodies. The preference leans towards PCR testing for its accuracy in detecting the virus directly. Gonorrhea testing is crucial due to the bacteria's growing antibiotic resistance. In addition to Chlamydia, NAATs serve as the gold standard for gonorrhea detection. For Hepatitis B, a viral infection affecting the liver, screening involves blood tests to detect HBV DNA levels, surface antigens, and antibodies. HIV testing is critical for early detection and management of the disease. Tests range from rapid antibody tests to combined antigen/antibody tests and nucleic acid tests (NATs). Human papillomavirus (HPV) is the most common sexually transmitted infection, with certain strains causing cervical cancer. Testing mainly targets women and involves detecting high-risk HPV DNA types. Syphilis testing typically involves initial non-treponemal antibody testing followed by confirmatory treponemal antibody tests. Traditional RPR (Rapid Plasma Reagin) tests are widely used with newer EIA (Enzyme Immunoassays).

End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time

Diagnostic centers specialize in the detection and analysis of various health conditions, including sexually transmitted diseases (STDs). They cater to patients requiring comprehensive screening and those who seek confidentiality. The demand in this segment is driven by their accessibility, quick turnaround time, and the availability of advanced testing technologies. Patients prefer diagnostic centers for routine screenings or when seeking anonymity. These centers are provided with the latest diagnostic tools and have specialists to offer counseling and immediate analysis. They are particularly favored by individuals not requiring hospital-based interventions. Hospitals and clinics provide various medical services, including STD testing. They are essential for individuals seeking comprehensive medical care, including diagnosis, treatment, and follow-up for STDs. This segment captures a significant market share due to its integral role in health care. Patients with symptoms of STDs or those in need of consultation alongside testing prefer hospitals and clinics. These facilities offer the advantage of integrated care, where patients can receive both diagnosis and treatment in one location. They are vital for handling more severe or complex STD cases that require specialized medical attention. Diagnostic centers are streamlined for timely and often more affordable testing services. They offer specialized care and may need more comprehensive medical support, which is available in hospitals. While hospitals and clinics provide comprehensive care, they may not match the diagnostic centers in terms of testing turnaround times. However, they prevail in offering detailed patient care, including treatment and counseling by specialists.

Regional Insights

The Americas, particularly the United States and Canada, represent a developed market with a strong emphasis on innovation and accessibility. In the United States, the market is defined by high consumer awareness and the presence of major companies leading research and development. Recent patents emphasize non-invasive testing methods and rapid results. Canada's market prioritizes accessible healthcare, with significant investments in public health campaigns and testing centers to increase STD awareness and prevention. The STD testing market in South America is progressing steadily, with Brazil carrying potential due to rising STD prevalence, governmental focus on public health campaigns, and improving healthcare facilities are instrumental in the market's expansion. The EMEA region presents a diverse landscape in the STD testing market. European Union countries exhibit a high demand for advanced diagnostic tests, driven by well-established healthcare systems and ongoing research initiatives. The region has witnessed growth in public-private partnerships for developing innovative testing solutions. In contrast, the Middle East focuses on increasing public awareness and breaking cultural barriers to STD testing with investments in educational campaigns and infrastructure. Africa faces unique challenges due to resource constraints while witnessing a rise in international aid and innovative testing solutions tailored to its needs, indicating a growing market for affordable and accessible STD testing. The APAC region is experiencing rapid development in the STD testing market, driven by rapidly expanding healthcare infrastructure, a growing middle-class population, and increased government initiatives toward public health. Countries such as China, India, and Australia are promoting this growth, focusing on awareness campaigns and integrating advanced technologies for diagnostic testing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the STD Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the STD Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the STD Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuquik by AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., ARCpoint Labs, Becton, Dickinson and Company, Bio Lab Diagnostics (I) Private Limited, Bio-Rad Laboratories, Inc., bioMerieux SA, BioReference Health, LLC by OPKO HEALTH, INC., Danaher Corporation, Daye Limited, Everlywell, Inc., F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Grifols, S.A., Hologic, Inc., JAL Medical by OK Biotech Co. Ltd., Laboratory Corporation of America Holdings, LifeCell, Lorne Laboratories Limited by Calibre Scientific, Meridian Bioscience Inc. by SD Biosensor, Inc., OraSure Technologies, Inc., Personalabs, Qiagen N.V., Quest Diagnostics, Inc., Randox Laboratories Ltd., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Viatris Inc., and Wondfo Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the STD Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Blood Tests
    • Lumbar Puncture
    • Swab Tests
    • Urine Tests
  • Product Type
    • Instruments
    • Reagents & Kits
  • Test Settings
    • Laboratory
    • Point of Care
  • Indication
    • Chlamydia
    • Genital Herpes
    • Gonorrhea
    • Hepatitis B
    • HIV/AIDS
    • Human Papillomavirus
    • Syphilis
  • End-user
    • Diagnostic Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the STD Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the STD Testing Market?

3. What are the technology trends and regulatory frameworks in the STD Testing Market?

4. What is the market share of the leading vendors in the STD Testing Market?

5. Which modes and strategic moves are suitable for entering the STD Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence and prevalence of sexually transmitted diseases worldwide
      • 5.1.1.2. Increasing awareness about STDs through education campaigns
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding strict regulatory guidelines for approval of STD testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technical advancements in STD disease diagnostics
      • 5.1.3.2. Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma associated with visiting specialized STD testing clinics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing preference for swab tests for STD testing for their non-invasive nature
    • 5.2.2. Product Type: Need for high-throughput instruments for high-volume testing environments
    • 5.2.3. Test Settings: Preference for POC tests for their unmatched convenience and speed
    • 5.2.4. Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies
    • 5.2.5. End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time
  • 5.3. Market Trend Analysis
    • 5.3.1. Growing popularity of at-home STD testing kits, coupled with a strong foothold of major companies across the Americas region
    • 5.3.2. Expanding government awareness initiatives against STDs due to the prevalence of STDs across the APAC region
    • 5.3.3. Stringent regulatory frameworks for diagnostic solutions and innovative product offerings for facilitating accessible STD testing across the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. STD Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Tests
  • 6.3. Lumbar Puncture
  • 6.4. Swab Tests
  • 6.5. Urine Tests

7. STD Testing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Kits

8. STD Testing Market, by Test Settings

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. Point of Care

9. STD Testing Market, by Indication

  • 9.1. Introduction
  • 9.2. Chlamydia
  • 9.3. Genital Herpes
  • 9.4. Gonorrhea
  • 9.5. Hepatitis B
  • 9.6. HIV/AIDS
  • 9.7. Human Papillomavirus
  • 9.8. Syphilis

10. STD Testing Market, by End-user

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals & Clinics

11. Americas STD Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific STD Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa STD Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic Alliance Advances Self-Test Solutions for Sexually Transmitted Diseases
    • 14.3.2. imaware Expands its Portfolio through binx health's Consumer Division Purchase
    • 14.3.3. FDA Approves Advanced At-home Chlamydia and Gonorrhea Test
    • 14.3.4. British Startup Launches Tampon That Offers STI Screening
    • 14.3.5. iHealth Launches Home Collection Kit for STD Testing
    • 14.3.6. Aptitude Medical Systems' Innovative Approach to Combat Sexually Transmitted Infections (STIs)
    • 14.3.7. LifeCell International Revolutionizes STD and HPV Screening with At-Home Test Kits
    • 14.3.8. Breakthrough 20-Minute Test for Gonorrhea and Chlamydia by Linear Diagnostics
    • 14.3.9. US BioTek's Innovative At-Home Testing Solutions
    • 14.3.10. Visby Medical Achieves FDA Clearance for Advanced Sexual Health Diagnostic Tool
    • 14.3.11. Mylab Launches a Range of Rapid Tests for STDs
    • 14.3.12. Strategic Partnership between Maternova and MedMira Enhances Global Access to Rapid Diagnostic Tests for Infectious Diseases
    • 14.3.13. Innovative Partnership Tackles STI Spike Among Gen Z with At-Home Testing Solutions
    • 14.3.14. Meridian Bioscience Joins Forces with SD Biosensor and SJL Partners

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. STD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. STD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. STD TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL STD TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 378. QATAR STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
  • TABLE 384. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
  • TABLE 385. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 386. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 387. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 388. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA STD